ADDENTAX GROUP CORP. current report, 14 September 2026

Addentax Group Corp. (ATXG) - Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed on September 14, 2026, by Addentax Group Corp., a Nevada corporation with principal executive offices in Shenzhen, China. The filing reports a material definitive agreement entered into on September 9, 2026.

Key Financial Metrics

The filing details a private placement transaction with the following financial terms:

  • Gross Proceeds: Approximately $2.5 million.
  • Shares Issued: 520,834 shares of common stock.
  • Purchase Price: $4.80 per share.
  • Use of Proceeds: General corporate purposes, including working capital and potential strategic investments.

The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity metrics as this is a transaction-specific report rather than a periodic financial statement.

Material Changes

The primary material change is the entry into Private Placement Agreements with investor Mr. Chan Chun Hong. This transaction represents a new source of capital and an increase in the company's outstanding share count upon closing.

Guidance, Outlook, and Risks

Management Commentary: The Company intends to utilize the net proceeds for working capital and strategic investments. The closing is subject to customary conditions.

Risks and Contingencies:

  • The shares are issued under Regulation S and have not been registered under the Securities Act of 1933.
  • The shares may not be offered or sold in the United States absent registration or an applicable exemption.
  • Issued shares will bear customary restrictive legends.
  • The transaction is contingent upon the satisfaction or waiver of closing conditions.

Investor Verification Checklist

  • Verify the final closing of the private placement and the actual receipt of the $2.5 million in proceeds.
  • Confirm the exact number of shares issued and the updated total share count post-closing.
  • Review the full Private Placement Agreement (Exhibit 10.1) for specific covenants and conditions.
  • Monitor future filings for the specific allocation of funds between working capital and strategic investments.